Sotera Health Co. (NASDAQ: SHC) reported Q2 EPS of $0.27, $0.03 better than the analyst estimate of $0.24. Revenue for the quarter came in at $267 million versus the consensus estimate of $256.3 million.

GUIDANCE:

Sotera Health Co. sees FY2022 EPS of $0.93-$0.97, versus the consensus of $0.96. Sotera Health Co. sees FY2022 revenue of $1-1.022 billion, versus the consensus of $1.02 billion.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.